These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9604895)

  • 1. Regulatory concerns at various phases of drug development.
    Aurecchia S; Orloff D; Sobel S
    Am J Cardiol; 1998 Apr; 81(8A):2F-4F. PubMed ID: 9604895
    [No Abstract]   [Full Text] [Related]  

  • 2. What kinds of studies should be required to probe efficacy and safety of drugs in special populations?
    LaRosa JC; Sneider GB; Boyle C
    Am J Cardiol; 1998 Apr; 81(8A):84F-87F. PubMed ID: 9604921
    [No Abstract]   [Full Text] [Related]  

  • 3. The challenge of regulating development and approval of drugs with pleiotropic action in cardiovascular disease.
    Temple R
    Am J Cardiol; 1998 Apr; 81(8A):5F-9F. PubMed ID: 9604896
    [No Abstract]   [Full Text] [Related]  

  • 4. Are the drug-regulatory agencies paper villains?
    Smith T
    Br Med J; 1980 Nov; 281(6251):1333-5. PubMed ID: 7002251
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigational new drug regs: icing or cake?
    Margolis RE
    Healthspan; 1988 Dec; 5(11):25-6. PubMed ID: 10291398
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS and FDA drug-approval policy: an evolving controversy.
    Gould SJ
    J Health Soc Policy; 1990; 2(2):39-46. PubMed ID: 10111761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilipemic drugs and the position of the FDA.
    Finkel MJ
    Adv Exp Med Biol; 1972; 26(0):263-5. PubMed ID: 4679645
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Policy in the Real World.
    Pullen LC
    Am J Transplant; 2019 Nov; 19(11):2963-2964. PubMed ID: 31742915
    [No Abstract]   [Full Text] [Related]  

  • 9. The regulation of investigational drugs.
    Kessler DA
    N Engl J Med; 1989 Feb; 320(5):281-8. PubMed ID: 2643051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
    Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins: underused by those who would benefit.
    Hulley SB; Grady D; Browner WS
    BMJ; 2000 Oct; 321(7267):971-2. PubMed ID: 11039939
    [No Abstract]   [Full Text] [Related]  

  • 12. History and application of drug safety and efficacy requirements in the United States.
    Wardell WM
    Agents Actions; 1978 Jun; 8(4):420-1. PubMed ID: 356565
    [No Abstract]   [Full Text] [Related]  

  • 13. Standards for the conduct of clinical trials and evaluation of bronchodilator drugs.
    Rosenthal RR
    J Allergy Clin Immunol; 1979 Dec; 64(6 pt 2):689-92. PubMed ID: 512265
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents.
    Davidson MH
    Am J Cardiol; 2001 Feb; 87(4A):1A-7A. PubMed ID: 11243600
    [No Abstract]   [Full Text] [Related]  

  • 15. EU law mandates drug testing in children.
    Sinha G
    J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's Bioresearch Monitoring Program.
    Kelsey FO
    Methods Find Exp Clin Pharmacol; 1982; 4(7):503-8. PubMed ID: 7169836
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad.
    Croft DE; Wykoff CC; Michels S; Chakravarthy U; Cruess AF
    Am J Ophthalmol; 2016 Sep; 169():xiv-xvi. PubMed ID: 27485923
    [No Abstract]   [Full Text] [Related]  

  • 18. International regulatory aspects of clinical periodontal research.
    Cooley WE; Castellion AW
    Ann Periodontol; 1997 Mar; 2(1):18-30. PubMed ID: 9151540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicolegal aspects of drug testing and systems of institutional review.
    Am J Cardiol; 1974 Oct; 34(4):482-4. PubMed ID: 4606800
    [No Abstract]   [Full Text] [Related]  

  • 20. Scientific misconduct in investigational drug trials.
    Shapiro MF; Charrow RP
    N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.